Aldo Scarpa

88.3k total citations · 8 hit papers
609 papers, 32.9k citations indexed

About

Aldo Scarpa is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Aldo Scarpa has authored 609 papers receiving a total of 32.9k indexed citations (citations by other indexed papers that have themselves been cited), including 372 papers in Oncology, 169 papers in Molecular Biology and 165 papers in Epidemiology. Recurrent topics in Aldo Scarpa's work include Pancreatic and Hepatic Oncology Research (231 papers), Neuroendocrine Tumor Research Advances (141 papers) and Cancer Genomics and Diagnostics (90 papers). Aldo Scarpa is often cited by papers focused on Pancreatic and Hepatic Oncology Research (231 papers), Neuroendocrine Tumor Research Advances (141 papers) and Cancer Genomics and Diagnostics (90 papers). Aldo Scarpa collaborates with scholars based in Italy, United States and United Kingdom. Aldo Scarpa's co-authors include Massimo Falconi, Giuseppe Zamboni, Paola Capelli, Carlo M. Croce, George A. Calin, Stefano Volinia, Claudio Luchini, Claudia Roldo, Chang‐Gong Liu and Manuela Ferracin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Aldo Scarpa

591 papers receiving 32.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A microRNA expression signature of human solid tumors defines cancer gene targets

2006 4.7k citations Stefano Volinia, George A. Calin et al. Proceedings of the National Academy of Sciences profile →
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

2006 1.2k citations Guido Rindi, Massimo Falconi et al. profile →
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system

2007 693 citations Guido Rindi, Aldo Scarpa et al. profile →
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach

2019 685 citations Claudio Luchini, Alessia Nottegar et al. profile →
MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior

2006 651 citations Claudia Roldo, Massimo Falconi et al. profile →
Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis

2003 575 citations Aldo Scarpa, Claudio Doglioni et al. profile →
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

2015 375 citations Michèle Milella, Matteo Brunelli et al. profile →
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism

2023 138 citations Andrea Mafficini, Aldo Scarpa et al. profile →

Peers

Countries citing papers authored by Aldo Scarpa

Since Specialization

Citations

This map shows the geographic impact of Aldo Scarpa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldo Scarpa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldo Scarpa more than expected).

Fields of papers citing papers by Aldo Scarpa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aldo Scarpa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldo Scarpa. The network helps show where Aldo Scarpa may publish in the future.

Co-authorship network of co-authors of Aldo Scarpa

This figure shows the co-authorship network connecting the top 25 collaborators of Aldo Scarpa. A scholar is included among the top collaborators of Aldo Scarpa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aldo Scarpa. Aldo Scarpa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Practical guidelines for molecular testing of cholangiocarcinoma in clinical practice: Italian experts’ position paper 2024 ·Critical Reviews in Oncology/Hematology ·Matteo Fassan, Valentina Angerilli, Nicola Normanno, Giancarlo Pruneri, Antonio Marchetti, Federica Grillo, Giuseppe Tonini, Aldo Scarpa, Lorenza Rimassa	8
2	Reappraising the Role of Intraoperative Neck Margin Revision in Postneoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma 2024 ·Annals of Surgery ·Giuseppe Malleo, Gabriella Lionetto, Stefano Crippa, Motaz Qadan, (unknown), Giulio Belfiori, Aldo Scarpa, (unknown), Fabio Casciani, Paola Mattiolo, Salvatore Paiella, Alessandro Esposito, Claudio Luchini, Cristina R. Ferrone, Keith D. Lillemoe, Carlos Fernández-del Castillo, Massimo Falconi, Roberto Salvia	3
3	The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma 2024 ·Cancer Gene Therapy ·(unknown), Emilia Alors‐Pérez, (unknown), (unknown), Marina Sánchez‐Frías, Andrea Mafficini, Juan L López-Cánovas, Corinne Bousquet, Manuel D. Gahete, Rita T. Lawlor, Raúl M. Luque, Aldo Scarpa, Álvaro Arjona‐Sánchez, Sergio Pedraza‐Arévalo, Alejandro Ibáñez‐Costa, Justo P. Castaño	2
4	Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature 2024 ·Journal of Gastrointestinal Cancer ·Paola Mattiolo, Mario De Bellis, Andrea Mafficini, Matteo Fassan, (unknown), (unknown), Samantha Bersani, Rita T. Lawlor, Michele Stanislaw Milella, Aldo Scarpa, Claudio Luchini, Andrea Ruzzenente	0
5	Comprehensive characterisation of acinar cystic transformation of the pancreas: a systematic review 2023 ·Journal of Clinical Pathology ·Paola Mattiolo, Huamin Wang, Olca Baştürk, Lodewijk A.A. Brosens, Seung‐Mo Hong, Volkan Adsay, Aldo Scarpa, Claudio Luchini	4
6	Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 2023 ·British journal of surgery ·Laura Maggino, Giuseppe Malleo, Stefano Crippa, Giulio Belfiori, Elisa Bannone, Gabriella Lionetto, Giulia Gasparini, Sara Nobile, Claudio Luchini, Paola Mattiolo, (unknown), Claudio Doglioni, Aldo Scarpa, Cristina R. Ferrone, Claudio Bassi, Carlos Fernández-del Castillo, Massimo Falconi, Roberto Salvia	5
7	Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases 2023 ·Pathology - Research and Practice ·Stefano Marletta, Vincenzo L’Imperio, Albino Eccher, (unknown), (unknown), Ilaria Girolami, Angelo Paolo Dei Tos, Marta Sbaraglia, Fabio Pagni, Matteo Brunelli, Andrea Marıno, Aldo Scarpa, Enrico Munari, Nicola Fusco, Liron Pantanowitz	27
8	Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance 2022 ·Biomedicines ·Αναστάσιος Γκουντάκος, Giovanni Centonze, Emanuele Vita, Lorenzo Belluomini, Michèle Milella, Emilio Bria, Massimo Milione, Aldo Scarpa, Michele Simbolo	10
9	Gene Expression Profiling of Pancreas Neuroendocrine Tumors with Different Ki67-Based Grades 2021 ·Cancers ·Michele Simbolo, (unknown), Andrea Mafficini, Claudio Luchini, Daniela Furlan, Frediano Inzani, Gianluigi Petrone, (unknown), Stefano La Rosa, Giovanni Schinzari, Antonio Bianchi, Ernesto Rossi, Roberta Menghi, Felice Giuliante, Stefania Boccia, Aldo Scarpa, Guido Rindi	18
10	Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS Network 2020 ·Journal of Clinical Pathology ·Caterina Fumagalli, Elena Guerini‐Rocco, Fiamma Buttitta, (unknown), (unknown), (unknown), Lara Felicioni, Giancarlo Troncone, Umberto Malapelle, Aldo Scarpa, Giuseppe Zamboni, Daniele Calistri, Massimo Barberis, Antonio Marchetti	3
11	Liver Tumor Burden in Pancreatic Neuroendocrine Tumors: CT Features and Texture Analysis in the Prediction of Tumor Grade and 18F-FDG Uptake 2020 ·Cancers ·(unknown), (unknown), Riccardo De Robertis, (unknown), (unknown), Chiara Longo, (unknown), Sara Cingarlini, Paola Capelli, Luca Landoni, Aldo Scarpa, Claudio Bassi, Mirko D’Onofrio	9
12	Preoperative Imaging Evaluation after Downstaging of Pancreatic Ductal Adenocarcinoma: A Multi-Center Study 2019 ·Cancers ·(unknown), Angela Calabrese, (unknown), Paola Capelli, (unknown), (unknown), (unknown), Paolo Tinazzi Martini, Riccardo De Robertis, Giovanni Carbognin, Giovanni Marchegiani, Aldo Scarpa, Roberto Salvia, Claudio Bassi, Mirko D’Onofrio	16
13	Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes 2019 ·Scientific Reports ·Chanthirika Ragulan, Katherine Eason, Elisa Fontana, Gift Nyamundanda, Noelia Tarazona, Yatish Patil, Pawan Poudel, Rita T. Lawlor, Maguy Del Rio, Si‐Lin Koo, (unknown), Francesco Sclafani, Ruwaida Begum, Larissa Mendes, Pierre Martineau, Aldo Scarpa, Andrés Cervantes, Iain Beehuat Tan, David Cunningham, Anguraj Sadanandam	29
14	Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 2017 ·Scientific Reports ·Claudio Luchini, Achim Fleischmann, Joost L. Boormans, Matteo Fassan, Alessia Nottegar, Paola Lucato, Brendon Stubbs, Marco Solmi, Antonio Benito Porcaro, Nicola Veronese, Matteo Brunelli, Aldo Scarpa, Liang Cheng	26
15	Early Epigenetic Downregulation of microRNA-192 Expression Promotes Pancreatic Cancer Progression 2016 ·Cancer Research ·Sandeep K. Botla, Soniya Savant, Pouria Jandaghi, Andrea S. Bauer, Oliver Mücke, Evgeny A. Moskalev, John P. Neoptolemos, Eithne Costello, William Greenhalf, Aldo Scarpa, Matthias M. Gaida, Markus W. Büchler, Oliver Strobel, Thilo Hackert, Nathalia A. Giese, Hellmut G. Augustin, Jörg D. Hoheisel	67
16	A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics 2015 ·Cancer Discovery ·Anguraj Sadanandam, Stephan Wullschleger, Costas A. Lyssiotis, Carsten Grötzinger, Stefano Barbi, Samantha Bersani, (unknown), (unknown), Andrea Mafficini, Rita T. Lawlor, Michele Simbolo, John M. Asara, Hendrik Bläker, Lewis C. Cantley, Bertram Wiedenmann, Aldo Scarpa, Douglas Hanahan	139
17	Targeted next‐generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 2014 ·The Journal of Pathology ·Eliana Amato, Marco Dal Molin, Andrea Mafficini, Jun Yu, Giuseppe Malleo, Borislav C. Rusev, Matteo Fassan, Davide Antonello, Yoshihiko Sadakari, M. Paola Castelli, Giuseppe Zamboni, Anirban Maitra, Roberto Salvia, Ralph H. Hruban, Claudio Bassi, Paola Capelli, Rita T. Lawlor, Michael Goggins, Aldo Scarpa	235
18	Toll-like Receptor 9 Agonist IMO Cooperates with Cetuximab in K - Ras Mutant Colorectal and Pancreatic Cancers 2011 ·Clinical Cancer Research ·Roberta Rosa, Davide Melisi, Vincenzo Damiano, Roberto Bianco, Sonia Garofalo, Teresa Gelardi, Sudhir Agrawal, Federica Di Nicolantonio, Aldo Scarpa, Alberto Bardelli, Giampaolo Tortora	44
19	Novel Somatic and Germline Mutations in Cancer Candidate Genes in Glioblastoma, Melanoma, and Pancreatic Carcinoma 2007 ·Cancer Research ·Asha Balakrishnan, Fonnet E. Bleeker, Simona Lamba, Monica Rodolfo, Maria Daniotti, Aldo Scarpa, Angela A. van Tilborg, Sieger Leenstra, Carlo Zanon, Alberto Bardelli	128
20	A microRNA expression signature of human solid tumors defines cancer gene targets breakdown → 2006 ·Proceedings of the National Academy of Sciences ·Stefano Volinia, George A. Calin, Chang‐Gong Liu, Stefan Ambs, Amelia Cimmino, Fabio Petrocca, Rosa Visone, Marilena V. Iorio, Claudia Roldo, Manuela Ferracin, Robyn L. Prueitt, (unknown), Giovanni Lanza, Aldo Scarpa, Andrea Vecchione, Massimo Negrini, Curtis C. Harris, Carlo M. Croce	4730

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact